Greene, Chris
Rebergue, Nicolas
Fewell, Gwen
Janigro, Damir
Godfrin, Yann
Campbell, Matthew
Lemarchant, Sighild
Article History
Received: 5 June 2024
Accepted: 15 September 2024
First Online: 27 September 2024
Declarations
:
: SL and NR are employed by Axoltis Pharma. SL is Chief Scientific Officer of Axoltis Pharma. YG is president of Godfrin Life-Sciences, giving advice to Axoltis Pharma, and is also Chief Executive Officer and a shareholder of Axoltis Pharma. GF is President and Chief Executive Officer of SynVivo. DJ is Chief Executive Officer of Flocel. MC is a member of the Scientific Advisory Board of Axoltis Pharma.